Network pharmacology and experimental verification-based strategy to explore the underlying mechanism of Liu Jun An Wei formula in the treatment of gastrointestinal reactions caused by chemotherapy for colorectal cancer

Background: Liu Jun An Wei formula (LJAW), derived from “Liu Jun Zi Decoction”, is a classical prescription of Tradition Chinese Medicine and has been used for the treatment of gastrointestinal reactions caused by chemotherapy for colorectal cancer (CRC) for many years. Its molecular mechanism remains to be further explored. Objective: To clarify the mechanism of LJAW in attenuating gastrointestinal reactions caused by chemotherapy for CRC. Methods: The 5-fluorouracil (5-FU) induced mouse and intestine organoid models were established to observe the effect of LJAW. The ingredients of LJAW were analyzed and identified by UPLC-Q-TOF-MS technology. Targets of LJAW and chemotherapy-induced gastrointestinal reactions were collected from several databases. “Ingredient-target” network and protein-protein interaction network were constructed based on network pharmacology. Then, gene ontology (GO) functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed. Subsequently, molecular docking method was used to verify the interaction between the core ingredients and key targets. The results were validated by both in vivo experiments and organoid experiments. Western Blot was used to analyze the influence of LJAW on key targets including PI3K, AKT1, MAPK1, MAPK14 proteins and their phosphorylated proteins. RT-qPCR and Western Blot were used to detect the mRNA and protein levels of apoptosis-related gene PUMA. Results: Compared with the 5-FU group, the LJAW group had better morphology in mouse small intestine and intestine organoids. In total, 18 core ingredients and 19 key targets were obtained from 97 ingredients and 169 common targets. KEGG analysis showed that the common targets were involved in PI3K/Akt, MAPK, apoptosis and other signal pathways, which are closely related to gastrointestinal injury. Experiments confirmed that LJAW lowered the expressions of phosphorylated proteins including p-PI3K, p-AKT1, p-MAPK1, and p-MAPK14 and reduced the mRNA and protein levels of PUMA. Conclusion: LJAW shows protective effect on 5-FU induced small intestine and intestinal organoids injury. LJAW attenuates gastrointestinal reactions caused by chemotherapy for CRC probably by regulating apoptosis-related genes through PI3K/AKT and MAPK signaling pathways.

[1]  Lin Ma,et al.  Xuanfei Baidu decoction attenuates intestinal disorders by modulating NF-κB pathway, regulating T cell immunity and improving intestinal flora. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  Harald H. H. W. Schmidt,et al.  Network pharmacology: curing causal mechanisms instead of treating symptoms. , 2021, Trends in pharmacological sciences.

[3]  M. Shirley.  Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting , 2021, Drugs.

[4]  Lin Li,et al.  Bioactive constituents and the molecular mechanism of Curcumae Rhizoma in the treatment of primary dysmenorrhea based on network pharmacology and molecular docking. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[5]  J. Yoneda,et al.  Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model , 2021, BMC Cancer.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  D. Peng,et al.  Exploration of the potential mechanism of the Tao Hong Si Wu Decoction for the treatment of postpartum blood stasis based on network pharmacology and in vivo experimental verification. , 2020, Journal of ethnopharmacology.

[8]  Madeline A. Lancaster,et al.  Rethinking organoid technology through bioengineering , 2020, Nature Materials.

[9]  K. Ray.  Next-generation intestinal organoids , 2020, Nature Reviews Gastroenterology & Hepatology.

[10]  H. Clevers,et al.  Homeostatic mini-intestines through scaffold-guided organoid morphogenesis , 2020, Nature.

[11]  Jin-yu Yang,et al.  Protective effect of Andrographolide on 5-Fu induced intestinal mucositis by regulating p38 MAPK signaling pathway. , 2020, Life sciences.

[12]  Huan Li,et al.  Isoprenaline protects intestinal stem cells from chemotherapy‐induced damage , 2020, British journal of pharmacology.

[13]  M. Gerling,et al.  Variations in the management of diarrhoea induced by cancer therapy: results from an international, cross-sectional survey among European oncologists , 2019, ESMO Open.

[14]  Tian Xie,et al.  Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response , 2019, Front. Oncol..

[15]  T. Nakagawa,et al.  Serotonin 3 receptor signaling regulates 5‐fluorouracil‐mediated apoptosis indirectly via TNF‐α production by enhancing serotonin release from enterochromaffin cells , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Weihong Cong,et al.  Chinese Herbal Medicines Facilitate the Control of Chemotherapy-Induced Side Effects in Colorectal Cancer: Progress and Perspective , 2018, Front. Pharmacol..

[17]  Jin-yu Yang,et al.  Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  G. Tataronis,et al.  Adherence to oral chemotherapy: Challenges and opportunities , 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[19]  Matthias P Lutolf,et al.  Progress and potential in organoid research , 2018, Nature Reviews Genetics.

[20]  R. Menon,et al.  Systematic review of p38 mitogen‐activated kinase and its functional role in reproductive tissues , 2018, American journal of reproductive immunology.

[21]  V. Cardoso,et al.  Conjugated linoleic acid prevents damage caused by intestinal mucositis induced by 5-fluorouracil in an experimental model. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  Lili Wang,et al.  Carboxymethyl pachyman (CMP) reduces intestinal mucositis and regulates the intestinal microflora in 5-fluorouracil-treated CT26 tumour-bearing mice. , 2018, Food & function.

[23]  P. Sangild,et al.  Animal models of chemotherapy-induced mucositis: translational relevance and challenges. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[24]  K. Nurgali,et al.  Impact of chemotherapy on gastrointestinal functions and the enteric nervous system. , 2017, Maturitas.

[25]  Hailian Shi,et al.  Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis , 2017, Front. Cell. Infect. Microbiol..

[26]  Feifei Guo,et al.  Screening and identification of critical transcription factors involved in the protection of cardiomyocytes against hydrogen peroxide-induced damage by Yixin-shu , 2017, Scientific Reports.

[27]  T. Nag,et al.  Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade. , 2017, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[28]  Ming-Shiun Tsai,et al.  Galangin ameliorates cisplatin‐induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF‐kappaB signaling , 2017, Toxicology and applied pharmacology.

[29]  Hongwei Wu,et al.  Identification of active components in Yixinshu Capsule with protective effects against myocardial dysfunction on human induced pluripotent stem cell-derived cardiomyocytes by an integrative approach. , 2017, Molecular bioSystems.

[30]  Yang Liu,et al.  [In vitro and in vivo intestinal absorption of Huanglian decoction in multi-component environment]. , 2017, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[31]  M. Di Maio,et al.  Patients’ perception of chemotherapy side effects: Expectations, doctor–patient communication and impact on quality of life – An Italian survey , 2017, European journal of cancer care.

[32]  U. Lindequist,et al.  Ergosterol Peroxide: A Mushroom-Derived Compound with Promising Biological Activities-A Review. , 2017, International journal of medicinal mushrooms.

[33]  J. Weitz,et al.  Gastrointestinal organoids: How they gut it out. , 2016, Developmental biology.

[34]  Rosanna Tarricone,et al.  Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review. , 2016, Critical reviews in oncology/hematology.

[35]  Kazunori Otsuka,et al.  Cohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome , 2015, BMC Pharmacology and Toxicology.

[36]  A. Karande,et al.  Endoplasmic Reticulum Stress-Mediated Activation of p38 MAPK, Caspase-2 and Caspase-8 Leads to Abrin-Induced Apoptosis , 2014, PloS one.

[37]  C. Barrios,et al.  Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  H. Kitano,et al.  Combining Machine Learning Systems and Multiple Docking Simulation Packages to Improve Docking Prediction Reliability for Network Pharmacology , 2013, PloS one.

[39]  Yan-jing Li,et al.  Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice. , 2013, Food chemistry.

[40]  C. Barrios,et al.  Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Hongjun Yang,et al.  Study on the application of intestinal absorption in vitro coupled with bioactivity assessment in Yuanhu Zhitong preparation , 2012 .

[42]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[43]  H. Inoue,et al.  Glycyrrhiza inflata-derived chalcones, Licochalcone A, Licochalcone B and Licochalcone D, inhibit phosphorylation of NF-kappaB p65 in LPS signaling pathway. , 2009, International immunopharmacology.

[44]  H. Shinmoto,et al.  Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells , 2007, British journal of pharmacology.

[45]  C. Zacker,et al.  The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. , 2000, The oncologist.